Cargando…

Increased Serum Interleukin-6 and Tumor Necrosis Factor Alpha Levels in Fabry Disease: Correlation with Disease Burden

OBJECTIVES: Fabry disease (FD) is an X-linked lysosomal disease caused by variants of the GLA gene; the formation of defective alpha-galactosidase A contributes to the accumulation of substrates in several organs. Chronic inflammation is thought to contribute to organ damage in FD patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosa, Nilton Salles, Bento, Judith Campos de Barros, Caparbo, Valéria de Falco, Pereira, Rosa Maria Rodrigues
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculdade de Medicina / USP 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266164/ https://www.ncbi.nlm.nih.gov/pubmed/34287477 http://dx.doi.org/10.6061/clinics/2021/e2643

Ejemplares similares

Depression, sleep disturbances, pain, disability and quality of LIFE in Brazilian Fabry disease patients
por: Rosa Neto, Nilton Salles, et al.
Publicado: (2019)

Genital angiokeratoma in a woman with Fabry disease: the dermatologist’s role
por: de Jesus, Patricia Moraes Resende, et al.
Publicado: (2018)

Brain MRI correlations with disease burden and biomarkers in Fabry disease
por: Zhao, Yawen, et al.
Publicado: (2023)

No deleterious effect of low dose methotrexate on titanium implant osseointegration in a rabbit model
por: Carvas, Janaina Badin, et al.
Publicado: (2011)

DNA methylation impact on Fabry disease
por: Di Risi, Teodolinda, et al.
Publicado: (2021)

Hot topics in Fabry disease
por: Cairns, Tereza, et al.
Publicado: (2018)

Fabry disease
por: Germain, Dominique P
Publicado: (2010)

Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease
por: Lee, Belinda T., et al.
Publicado: (2015)

Curcumin half analog modulates interleukin-6 and tumor necrosis factor-alpha in inflammatory bowel disease
por: Kondamudi, Phani Krishna, et al.
Publicado: (2015)

Evaluation of serum level of tumor necrosis factor-alpha and interleukin-6 in patients with congenital heart disease
por: Noori, Noor Mohammad, et al.
Publicado: (2016)

Tumor Necrosis Factor-Alpha and Interleukin 6 in Human Periapical Lesions
por: Pršo, Ivana Brekalo, et al.
Publicado: (2007)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

Globotriaosylsphingosine Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease
por: Namdar, Mehdi, et al.
Publicado: (2012)

A Novel Frameshift Mutation of Galactosidase-alpha in Fabry Disease Restricted to Dermatologic Manifestations
por: Kim, Dae Hun, et al.
Publicado: (2013)

Affective and cognitive behavior in the alpha-galactosidase A deficient mouse model of Fabry disease
por: Hofmann, Lukas, et al.
Publicado: (2017)

Tumor Necrosis Factor-Alpha and Interleukin-1 Alpha as Predictors of Survival in Peritonitis: A Pilot Study
por: Afuwape, Oludolapo Ola, et al.
Publicado: (2018)

Transcriptomic characterization of classical monocytes highlights the involvement of immuno-inflammation in bone erosion in Rheumatoid Arthritis
por: Sales, Lucas Peixoto, et al.
Publicado: (2023)

Kidney Transplant in Fabry Disease: A Revision of the Literature
por: Capelli, Irene, et al.
Publicado: (2020)

Cornea verticillata caused by Fabry diseaseCórnea verticilata por doença de Fabry
por: Costa, Ana Luiza Fontes de Azevedo, et al.
Publicado: (2014)

Correction: Globotriaosylceramide Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease
por: Namdar, Mehdi, et al.
Publicado: (2012)

Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
por: Lenders, Malte, et al.
Publicado: (2016)

Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease
por: Monticelli, Maria, et al.
Publicado: (2023)

Cardiac magnetic resonance in Fabry disease
por: Lanzillo, Chiara, et al.
Publicado: (2023)

GLA Gene Mutation in Hypertrophic Cardiomyopathy with a New Variant Description: Is it Fabry's Disease?
por: Chaves-Markman, Ândrea Virgínia, et al.
Publicado: (2019)

Multidisciplinary Management of Fabry Disease: Current Perspectives
por: Paim-Marques, Luciana, et al.
Publicado: (2022)

Fabry Disease and Early Stroke
por: Feldt-Rasmussen, U.
Publicado: (2011)

Endoscopic images in Fabry disease
por: Kouvaras, Stergios N.
Publicado: (2012)

Motor involvement in Fabry disease
por: Cocozza, Sirio, et al.
Publicado: (2017)

Fabry disease and incidence of cancer
por: Bird, Sarah, et al.
Publicado: (2017)

Developments in the treatment of Fabry disease
por: van der Veen, Sanne J., et al.
Publicado: (2020)

Biomarkers in Anderson–Fabry Disease
por: Simonetta, Irene, et al.
Publicado: (2020)

Chaperone Therapy in Fabry Disease
por: Weidemann, Frank, et al.
Publicado: (2022)

Cardiac MRI in Fabry disease
por: Umer, Muhammad, et al.
Publicado: (2023)

Artificial Intelligence, Fabry Disease…
por: Erol, Çetin
Publicado: (2023)

Management of Hypertension in Fabry Disease
por: Kim, Su Hyun, et al.
Publicado: (2023)

Tumour necrosis factor-alpha and interleukin-8 inhibit neutrophil migration in vitro and in vivo
por: Cunha, F. Q., et al.
Publicado: (1992)

Plasma Levels of Tumor Necrosis Factor-Alpha and Interleukin-6 in Obsessive Compulsive Disorder
por: Konuk, N., et al.
Publicado: (2007)

Tumor necrosis factor-alpha/interleukin-10 balance in normal and cystic fibrosis children.
por: Shmarina, G V, et al.
Publicado: (2001)

Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice
Publicado: (1988)

Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_43i766a2gj0oo6s1knjicj8a01